ROTAVIRUS (ROTARIX) VACCINE

VACCINE USAGE: ROTARIX is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9). ROTARIX is approved for use in infants 6 weeks to 24 weeks of age.

VACCINE DOSAGE: each dose is 1 mL administered orally.

  • Administer first dose to infants beginning at 6 weeks of age.
  • Administer second dose after an interval of at least 4 weeks and prior to 24 weeks of age.

VACCINE INGEDIENTS: amino acids, dextran, sorbitol, sucrose, calcium carbonate, xanthan, Dulbecco’s modified Eagle Medium (DMEM) [Porcine circovirus type 1 (PCV-1) is present in Rotarix. PCV-1 is not known to cause disease in humans].

LIVE VIRUS VACCINE THAT HAS THE POTENTIAL TO SHED

ADVERSE VACCINE REACTIONS: fussiness, cough/ runny nose, fever, loss of appetite, vomiting, diarrhea, death mostly caused by pneumonia, kawasaki disease, intussusception (including death), recurrent intussusception (including death), hematochezia, gastroenteritis with vaccine trial shedding in infants with severe combined immunodeficiency disease (SCID).